LarmorBio Presents New Research at ENDO on the Ability of MMR Technology to Assess Cardiometabolic Disease Risk
BOSTON, MA, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- LarmorBio today announced the presentation of three groundbreaking studies at the U.S. Endocrine Society (ENDO) 2025 conference, showcasing the power of its proprietary microscale …